Showing 4391-4400 of 21464 results for "".
- Innovations in Open Science and Viral Research: A New Era for Healthcare Professionalshttps://reachmd.com/news/innovations-in-open-science-and-viral-research-a-new-era-for-healthcare-professionals/2471255/As the healthcare landscape continues to evolve, new platforms and research tools are redefining how professionals engage with scientific data and manage global health challenges. From enhancing event management with open science principles to unraveling the complex mechani
- Expanding Human Viruses List: Implications for Global Healthhttps://reachmd.com/news/expanding-human-viruses-list-implications-for-global-health/2471214/The rapidly expanding list of human viruses, driven by factors like climate change and globalization, poses significant challenges to global health. New metagenomic discoveries highlight the urgent need for enhanced surveillance and preparedness strategies.
- Impact of COVID-19 on Ophthalmic Procedures Among Medicare Beneficiarieshttps://reachmd.com/news/impact-of-covid-19-on-ophthalmic-procedures-among-medicare-beneficiaries/2471195/The COVID-19 pandemic significantly disrupted healthcare systems worldwide, and ophthalmic procedures among Medicare beneficiaries in the U.S. were no exception. Recent studies have shown a substantial decline in these procedures, unveiling disparities across regions and ty
- Guidelines for Safe Bariatric Surgery Tourism: European Consensus Insightshttps://reachmd.com/news/guidelines-for-safe-bariatric-surgery-tourism-european-consensus-insights/2471203/As the demand for bariatric and metabolic surgeries grows amidst limited local resources, European experts have developed consensus guidelines to enhance safety in medical tourism for obesity treatments. The Rising Trend of Bariatric Surgery To
- Innovative Colloidal Drug Delivery Extends Glaucoma Treatment Durationhttps://reachmd.com/news/innovative-colloidal-drug-delivery-extends-glaucoma-treatment-duration/2471198/A groundbreaking study unveils a novel colloidal drug delivery system that significantly extends the efficacy of glaucoma treatment, potentially reducing the need for frequent medication administration. A Paradigm Shift in Glaucoma Treatment
- Innovative Nasal COVID-19 Vaccine Set for U.S. Clinical Trialshttps://reachmd.com/news/innovative-nasal-covid-19-vaccine-set-for-us-clinical-trials/2471130/Exciting advancements in nasal COVID-19 vaccine technology are poised to bring a new approach to controlling virus transmission, as phase 1 clinical trials prepare to launch in the U.S. this spring. Revolutionizing Vaccine Delivery The nasal COVI
- The Impact of Work on Young Adults' Health Behaviors: New Insightshttps://reachmd.com/news/the-impact-of-work-on-young-adults-health-behaviors-new-insights/2471049/What's New Recent research from the University of Cambridge has shed light on the health behavior shifts young adults experience when they start working. These changes, particularly in physical activity and sleep patterns, vary depending on the nature of their jobs.
- New Insights into Senescence in Melanoma and Cancer Therapyhttps://reachmd.com/news/new-insights-into-senescence-in-melanoma-and-cancer-therapy/2471035/What's New A recent study led by the University of Barcelona uncovers a molecular mechanism that could redefine strategies to eliminate senescent cells in cancer patients post-treatment. Significance Understanding this mechanism is significant as it
- Socioeconomic Disadvantages Impact Survival After Heart Transplantshttps://reachmd.com/news/socioeconomic-disadvantages-impact-survival-after-heart-transplants/2471018/What's New A recent UCLA Health study found that Medicaid recipients undergoing heart transplants have poorer survival rates compared to others, largely due to socio-economic disadvantages. Significance The article discusses a UCLA Health study showi
- Galderma Seeks to Address Facial Volume Loss From GLP-1 Medications with Injectable Portfoliohttps://reachmd.com/news/new-datas-promising-results-to-predominant-aesthetic-concerns-for-prescription-weight-loss-medications/2473730/Galderma announced positive first results last week from a trial designed to explore the benefits of Restylane Lyft or Contour in combination with Sculptra in patients with medication-driven weight loss with associated facial volume loss. According to a press release from the manufacturer,